{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:30:41Z","timestamp":1768739441363,"version":"3.49.0"},"reference-count":69,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T00:00:00Z","timestamp":1496188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Searching of new enantiomerically pure chiral derivatives of xanthones (CDXs) with potential pharmacological properties, particularly those with anti-inflammatory activity, has remained an area of interest of our group. Herein, we describe in silico studies and in vitro inhibitory assays of cyclooxygenases (COX-1 and COX-2) for different enantiomeric pairs of CDXs. The evaluation of the inhibitory activities was performed by using the COX Inhibitor Screening Assay Kit. Docking simulations between the small molecules (CDXs; known ligands and decoys) and the enzyme targets were undertaken with AutoDock Vina embedded in PyRx\u2014Virtual Screening Tool software. All the CDXs evaluated exhibited COX-1 and COX-2 inhibition potential as predicted. Considering that the (S)-(\u2212)-enantiomer of the nonsteroidal anti-inflammatory drug ketoprofen preferentially binds to albumin, resulting in lower free plasma concentration than (R)-(+)-enantiomer, protein binding affinity for CDXs was also evaluated by spectrofluorimetry as well as in in silico. For some CDXs enantioselectivity was observed.<\/jats:p>","DOI":"10.3390\/ph10020050","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T10:41:04Z","timestamp":1496227264000},"page":"50","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Chiral Derivatives of Xanthones: Investigation of the Effect of Enantioselectivity on Inhibition of Cyclooxygenases (COX-1 and COX-2) and Binding Interaction with Human Serum Albumin"],"prefix":"10.3390","volume":"10","author":[{"given":"Carla","family":"Fernandes","sequence":"first","affiliation":[{"name":"Laborat\u00f3rio de Qu\u00edmica Org\u00e2nica e Farmac\u00eautica, Departamento de Ci\u00eancias Qu\u00edmicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua Jorge Viterbo Ferreira n\u00ba 228, 4050-313 Porto, Portugal"},{"name":"Centro Interdisciplinar de Investiga\u00e7\u00e3o Marinha e Ambiental (CIIMAR), Universidade do Porto, Edif\u00edcio do Terminal de Cruzeiros do Porto de Leix\u00f5es, Av. General Norton de Matos s\/n, 4050-208 Matosinhos, Portugal"}]},{"given":"Andreia","family":"Palmeira","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Qu\u00edmica Org\u00e2nica e Farmac\u00eautica, Departamento de Ci\u00eancias Qu\u00edmicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua Jorge Viterbo Ferreira n\u00ba 228, 4050-313 Porto, Portugal"},{"name":"Centro Interdisciplinar de Investiga\u00e7\u00e3o Marinha e Ambiental (CIIMAR), Universidade do Porto, Edif\u00edcio do Terminal de Cruzeiros do Porto de Leix\u00f5es, Av. General Norton de Matos s\/n, 4050-208 Matosinhos, Portugal"}]},{"given":"In\u00eas","family":"Ramos","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Qu\u00edmica Org\u00e2nica e Farmac\u00eautica, Departamento de Ci\u00eancias Qu\u00edmicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua Jorge Viterbo Ferreira n\u00ba 228, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4015-6996","authenticated-orcid":false,"given":"Carlos","family":"Carneiro","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Qu\u00edmica Org\u00e2nica e Farmac\u00eautica, Departamento de Ci\u00eancias Qu\u00edmicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua Jorge Viterbo Ferreira n\u00ba 228, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5731-5789","authenticated-orcid":false,"given":"Carlos","family":"Afonso","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Qu\u00edmica Org\u00e2nica e Farmac\u00eautica, Departamento de Ci\u00eancias Qu\u00edmicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua Jorge Viterbo Ferreira n\u00ba 228, 4050-313 Porto, Portugal"},{"name":"Centro Interdisciplinar de Investiga\u00e7\u00e3o Marinha e Ambiental (CIIMAR), Universidade do Porto, Edif\u00edcio do Terminal de Cruzeiros do Porto de Leix\u00f5es, Av. General Norton de Matos s\/n, 4050-208 Matosinhos, Portugal"}]},{"given":"Maria","family":"Tiritan","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Qu\u00edmica Org\u00e2nica e Farmac\u00eautica, Departamento de Ci\u00eancias Qu\u00edmicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua Jorge Viterbo Ferreira n\u00ba 228, 4050-313 Porto, Portugal"},{"name":"Centro Interdisciplinar de Investiga\u00e7\u00e3o Marinha e Ambiental (CIIMAR), Universidade do Porto, Edif\u00edcio do Terminal de Cruzeiros do Porto de Leix\u00f5es, Av. General Norton de Matos s\/n, 4050-208 Matosinhos, Portugal"},{"name":"CESPU, Instituto de Investiga\u00e7\u00e3o e Forma\u00e7\u00e3o Avan\u00e7ada em Ci\u00eancias e Tecnologias da Sa\u00fade, Rua Central de Gandra 1317, 4585-116 Gandra PRD, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0715-1779","authenticated-orcid":false,"given":"Honorina","family":"Cidade","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Qu\u00edmica Org\u00e2nica e Farmac\u00eautica, Departamento de Ci\u00eancias Qu\u00edmicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua Jorge Viterbo Ferreira n\u00ba 228, 4050-313 Porto, Portugal"},{"name":"Centro Interdisciplinar de Investiga\u00e7\u00e3o Marinha e Ambiental (CIIMAR), Universidade do Porto, Edif\u00edcio do Terminal de Cruzeiros do Porto de Leix\u00f5es, Av. General Norton de Matos s\/n, 4050-208 Matosinhos, Portugal"}]},{"given":"Paula","family":"Pinto","sequence":"additional","affiliation":[{"name":"REQUIMTE, Departamento de Ci\u00eancias Qu\u00edmicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228, 4050\u2011313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6539-1741","authenticated-orcid":false,"given":"M.","family":"Saraiva","sequence":"additional","affiliation":[{"name":"REQUIMTE, Departamento de Ci\u00eancias Qu\u00edmicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228, 4050\u2011313 Porto, Portugal"}]},{"given":"Salette","family":"Reis","sequence":"additional","affiliation":[{"name":"REQUIMTE, Departamento de Ci\u00eancias Qu\u00edmicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228, 4050\u2011313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4676-1409","authenticated-orcid":false,"given":"Madalena","family":"Pinto","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Qu\u00edmica Org\u00e2nica e Farmac\u00eautica, Departamento de Ci\u00eancias Qu\u00edmicas, Faculdade de Farm\u00e1cia, Universidade do Porto, Rua Jorge Viterbo Ferreira n\u00ba 228, 4050-313 Porto, Portugal"},{"name":"Centro Interdisciplinar de Investiga\u00e7\u00e3o Marinha e Ambiental (CIIMAR), Universidade do Porto, Edif\u00edcio do Terminal de Cruzeiros do Porto de Leix\u00f5es, Av. General Norton de Matos s\/n, 4050-208 Matosinhos, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2017,5,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Tiritan, M.E., Ribeiro, A.R., Fernandes, C., and Pinto, M. (2016). Chiral pharmaceuticals. Kirk-Othmer Encyclopedia of Chemical Technology, John Wiley & Sons, Inc.","DOI":"10.1002\/0471238961.1608011823092009.a01.pub2"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12210-012-0220-2","article-title":"Chirality and its implications for the pharmaceutical industry","volume":"24","author":"Blaser","year":"2013","journal-title":"Rend. Lincei"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/bdd.517","article-title":"Drug disposition in three dimensions: An update on stereoselectivity in pharmacokinetics","volume":"27","author":"Brocks","year":"2006","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1021\/ed084p2012","article-title":"Unequal activities of enantiomers via biological receptors: Examples of chiral drug, pesticide, and fragrance molecules","volume":"84","author":"Mannschreck","year":"2007","journal-title":"J. Chem. Educ."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/toxsci\/kfp097","article-title":"Chiral toxicology: It's the same thing only different","volume":"110","author":"Smith","year":"2009","journal-title":"Toxicol. Sci."},{"key":"ref_6","first-page":"10","article-title":"Exploiting the power of stereochemistry in drugs: An overview of racemic and enantiopure drugs","volume":"1","author":"Sekhon","year":"2013","journal-title":"J. Mod. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S1359-6446(97)01010-6","article-title":"Stereoselectivity of drug action","volume":"2","author":"Triggle","year":"1997","journal-title":"Drug Discov. Today"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1039\/c000408c","article-title":"Pharmacologically active compounds in the environment and their chirality","volume":"39","year":"2010","journal-title":"Chem. Soc. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/0014-2999(90)93806-2","article-title":"Biological activity of ketoprofen and its optical isomers","volume":"183","author":"Moreno","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-2999(99)00108-9","article-title":"ketoprofen S(+)-enantiomer inhibits prostaglandin production and cell growth in 3T6 fibroblast cultures","volume":"370","author":"Moreno","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1073\/pnas.0409721102","article-title":"The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid x receptor and induces tumor-selective apoptosis","volume":"102","author":"Kolluri","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1517\/17460441.2.1.51","article-title":"The importance of plasma protein binding in drug discovery","volume":"2","author":"Trainor","year":"2007","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kerns, E.H., and Di, L. (2008). Drug-Like Properties: Concepts, Structure Design and Methods, Elsevier Inc.","DOI":"10.1016\/B978-012369520-8.50025-5"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/15216540500404093","article-title":"The extraordinary ligand binding properties of human serum albumin","volume":"57","author":"Fasano","year":"2005","journal-title":"IUBMB Life"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/aps.2013.78","article-title":"Stereoselective binding of chiral drugs to plasma proteins","volume":"34","author":"Shen","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_16","unstructured":"Goodman, G. (1996). The Pharmacological Basis of Therapeutics, McGraw-Hill. [9th ed.]."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0006-2952(02)01074-2","article-title":"Predicting plasma protein binding of drugs: A new approach","volume":"64","author":"Kratochwil","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-4347(95)00425-4","article-title":"Drug-protein binding studies\u2014new trends in analytical and experimental methodology","volume":"677","author":"Oravcova","year":"1996","journal-title":"J. Chromatogr. B Biomed. Appl."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1016\/j.bmc.2007.09.006","article-title":"Paclitaxel binding to the fatty acid-induced conformation of human serum albumin\u2014automated docking studies","volume":"15","author":"Paal","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.foodchem.2016.06.007","article-title":"Multispectroscopic and docking studies on the binding of chlorogenic acid isomers to human serum albumin: Effects of esteryl position on affinity","volume":"212","author":"Tang","year":"2016","journal-title":"Food Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/187152009787047699","article-title":"Fused xanthone derivatives as antiproliferative agents","volume":"9","author":"Pouli","year":"2009","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1747-0285.2010.00978.x","article-title":"Insights into the in vitro antitumor mechanism of action of a new pyranoxanthone","volume":"76","author":"Palmeira","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1016\/j.ejmech.2009.04.011","article-title":"Bromoalkoxyxanthones as promising antitumor agents: Synthesis, crystal structure and effect on human tumor cell lines","volume":"44","author":"Sousa","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1139\/V09-123","article-title":"Cowaxanthone f, a new tetraoxygenated xanthone, and other anti-inflammatory and antioxidant compounds from garcinia cowa","volume":"87","author":"Panthong","year":"2009","journal-title":"Can. J. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-2952(01)00810-3","article-title":"Inhibition of cyclooxygenase and prostaglandin E2 synthesis by \u03b3-mangostin, a xanthone derivative in mangosteen, in C6 rat glioma cells","volume":"63","author":"Nakatani","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1124\/mol.104.002626","article-title":"\u0393-mangostin inhibits inhibitor-\u03baB kinase activity and decreases lipopolysaccharide-lnduced cyclooxygenase-2 gene expression in C6 rat glioma cells","volume":"66","author":"Nakatani","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ejmech.2016.03.058","article-title":"Recent insight into the biological activities of synthetic xanthone derivatives","volume":"116","author":"Shagufta","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.2174\/092986705774370691","article-title":"Xanthone derivatives: New insights in biological activities","volume":"12","author":"Pinto","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.2174\/092986705774370682","article-title":"Naturally-occurring xanthones: Recent developments","volume":"12","author":"Vieira","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1021\/cr100446h","article-title":"Xanthones from fungi, lichens, and bacteria: The natural products and their synthesis","volume":"112","author":"Masters","year":"2012","journal-title":"Chem. Rev."},{"key":"ref_31","first-page":"1","article-title":"Xanthones from marine-derived microorganisms: Isolation, structure elucidation, and biological activities","volume":"Vol. 27","author":"Pinto","year":"2014","journal-title":"Encyclopedia of Analytical Chemistry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.bmc.2013.03.079","article-title":"Multidimensional optimization of promising antitumor xanthone derivatives","volume":"21","author":"Azevedo","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.2174\/092986705774370736","article-title":"Synthesis of xanthones: An overview","volume":"12","author":"Sousa","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/cbdd.12842","article-title":"Design, synthesis, and anticonvulsant activity of some derivatives of xanthone with aminoalkanol moieties","volume":"89","author":"Waszkielewicz","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.bmc.2012.11.014","article-title":"Synthesis and preliminary evaluation of pharmacological properties of some piperazine derivatives of xanthone","volume":"21","author":"Szkaradek","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7234","DOI":"10.1016\/j.bmc.2008.06.039","article-title":"Anticonvulsant activity of some xanthone derivatives","volume":"16","author":"Marona","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1522-2675(200209)85:9<2862::AID-HLCA2862>3.0.CO;2-R","article-title":"Isomeric kielcorins and dihydroxyxanthones: Synthesis, structure elucidation, and inhibitory activities of growth of human cancer cell lines and on the proliferation of human lymphocytes in vitro","volume":"85","author":"Sousa","year":"2002","journal-title":"Hel. Chim. Acta"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1021\/jm00113a027","article-title":"Potential antitumor agents. 63. Structure-activity relationships for side-chain analogues of the colon 38 active agent 9-oxo-9h-xanthene-4-acetic acid","volume":"34","author":"Rewcastle","year":"1991","journal-title":"J. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.chroma.2005.12.071","article-title":"Multimilligram enantioresolution of low-solubility xanthonolignoids on polysaccharide chiral stationary phases using a solid-phase injection system","volume":"1120","author":"Sousa","year":"2006","journal-title":"J. Chromatogr. A"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bmc.2013.12.042","article-title":"New chiral derivatives of xanthones: Synthesis and investigation of enantioselectivity as inhibitors of growth of human tumor cell lines","volume":"22","author":"Fernandes","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2012.06.049","article-title":"Synthesis of new chiral xanthone derivatives acting as nerve conduction blockers in the rat sciatic nerve","volume":"55","author":"Fernandes","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"ref_42","unstructured":"Cidade, H., Rocha, V., Palmeira, A., Marques, C., Tiritan, M.E., Ferreira, H., Lobo, J.S., Almeida, I.F., Sousa, M.E., and Pinto, M. (2017). In silico and in vitro antioxidant and cytotoxicity evaluation of oxygenated xanthone derivatives. Arab. J. Chem., in press."},{"key":"ref_43","unstructured":"Pereira, D., Lima, R.T., Palmeira, A., Seca, H., Soares, J., Gomes, S., Raimundo, L., Maciel, C., Pinto, M., and Sousa, E. (2016). Design and synthesis of new inhibitors of p53-MDM2 interaction with a chalcone scaffold. Arab. J. Chem., in press."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1747-0285.2011.01089.x","article-title":"New uses for old drugs: Pharmacophore-based screening for the discovery of p-glycoprotein inhibitors","volume":"78","author":"Palmeira","year":"2011","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/cbdd.12109","article-title":"Sulfated small molecules targeting EBV in Burkitt lymphoma: From in silico screening to the evidence of in vitro effect on viral episomal DNA","volume":"81","author":"Lima","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1053\/bega.2001.0236","article-title":"Cox-1 and cox-2 inhibitors","volume":"15","author":"Hawkey","year":"2001","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1517\/14656566.2013.783568","article-title":"Valdecoxib: The rise and fall of a cox-2 inhibitor","volume":"14","author":"Atukorala","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ejmech.2012.01.018","article-title":"Synthesis, evaluation and docking studies on 3-alkoxy-4-methanesulfonamido acetophenone derivatives as non-ulcerogenic anti-inflammatory agents","volume":"49","author":"Bali","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.bmc.2011.12.030","article-title":"Design, synthesis, biological evaluation, and comparative cox1 and cox2 docking of p-substituted benzylidenamino phenyl esters of ibuprofenic and mefenamic acids","volume":"20","author":"Hegazy","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1016\/j.bmc.2012.03.044","article-title":"Synthesis, biological evaluation and molecular modeling study of pyrazole and pyrazoline derivatives as selective cox-2 inhibitors and anti-inflammatory agents. Part 2","volume":"20","author":"ElTahir","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2174\/0929867003374255","article-title":"Cox-2 selectivity and inflammatory processes","volume":"7","author":"Ryn","year":"2000","journal-title":"Curr. Med. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.ejmech.2011.02.013","article-title":"Synthesis, anti-inflammatory activity and cox-1\/cox-2 inhibition of novel substituted cyclic imides. Part 1: Molecular docking study","volume":"46","author":"ElTahir","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"45763","DOI":"10.1074\/jbc.M305481200","article-title":"A novel mechanism of cyclooxygenase-2 inhibition involving interactions with ser-530 and tyr-385","volume":"278","author":"Rowlinson","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1023\/A:1007537520620","article-title":"A rapid spectrofluorimetric technique for determining drug-serum protein binding suitable for high-throughput screening","volume":"17","author":"Parikh","year":"2000","journal-title":"Pharm. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1042\/bj3490813","article-title":"Role of arg-410 and tyr-411 in human serum albumin for ligand binding and esterase-like activity","volume":"349","author":"Watanabe","year":"2000","journal-title":"Biochem. J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jmb.2005.07.075","article-title":"Structural basis of the drug-binding specificity of human serum albumin","volume":"353","author":"Ghuman","year":"2005","journal-title":"J. Mol. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1021\/jp3069877","article-title":"Biophysical insight into furosemide binding to human serum albumin: A study to unveil its impaired albumin binding in uremia","volume":"117","author":"Zaidi","year":"2013","journal-title":"J. Phys. Chem. B"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Karthikeyan, S., Bharanidharan, G., Mani, K.A., Srinivasan, N., Kesherwani, M., Velmurugan, D., Aruna, P., and Ganesan, S. (2016). Determination on the binding of thiadiazole derivative to human serum albumin: A spectroscopy and computational approach. J. Biomol. Struct. Dyn., 1\u201312.","DOI":"10.1080\/07391102.2016.1162751"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1007\/s00894-014-2365-7","article-title":"Study of interaction of human serum albumin with curcumin by nmr and docking","volume":"20","author":"Singh","year":"2014","journal-title":"J. Mol. Model."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.chroma.2012.07.058","article-title":"Resolution and determination of enantiomeric purity of new chiral derivatives of xanthones using polysaccharide-based stationary phases","volume":"1269","author":"Fernandes","year":"2012","journal-title":"J. Chromatogr. A"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chroma.2012.04.011","article-title":"Enantioseparation and chiral recognition mechanism of new chiral derivatives of xanthones on macrocyclic antibiotic stationary phases","volume":"1241","author":"Fernandes","year":"2012","journal-title":"J. Chromatogr. A"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1021\/ed070p425","article-title":"Ribonuclease t1 and alcohol dehydrogenase fluorescence quenching by acrylamide\u2014A laboratory experiment for undergraduate students","volume":"70","author":"Coutinho","year":"1993","journal-title":"J. Chem. Edu."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"10046","DOI":"10.1021\/ja00051a042","article-title":"Application of a universal force field to main group compounds","volume":"114","author":"Casewit","year":"1992","journal-title":"J. Am. Chem. Soc."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/0040-4020(80)80168-2","article-title":"Iterative partial equalization of orbital electronegativity\u2014A rapid access to atomic charges","volume":"36","author":"Gasteiger","year":"1980","journal-title":"Tetrahedron"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1021\/jm300687e","article-title":"Directory of useful decoys, enhanced (DUD-E): Better ligands and decoys for better benchmarking","volume":"55","author":"Mysinger","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"D345","DOI":"10.1093\/nar\/gku1214","article-title":"The RCSB protein data bank: Views of structural biology for basic and applied research and education","volume":"43","author":"Rose","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Autodock vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with pymol and autodock\/vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J. Comput. Aided Mol. Des."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/10\/2\/50\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:37:29Z","timestamp":1760207849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/10\/2\/50"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,31]]},"references-count":69,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,6]]}},"alternative-id":["ph10020050"],"URL":"https:\/\/doi.org\/10.3390\/ph10020050","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,31]]}}}